Therapy News and Research

RSS

Bedfont takes new strides to enhance well-being of employees

After the push from The Duke and Duchess of Cambridge for the Heads Together campaign, mental health and well-being at work has come under the spotlight.

From Bedfont® Scientific Ltd 9 May 2018

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study by SWOG, an international clinical trials network funded by the National Cancer Institute.

9 May 2018

Invasive surgery should be done for select patients with acid reflux, says study

As the number of Americans with acid reflux grows, a study by researchers at the University of Colorado Anschutz Medical Campus says invasive procedures to treat those who don't respond to medication should be done for select patients.

8 May 2018

Centrosome amplification may contribute to initiation of cancers, research suggests

Cells begin to accumulate centrosomes - organelles that play a vital role during cell division - before they transform into cancer cells, according to a new study of patients with Barrett's esophagus condition, which is associated with esophageal cancer.

8 May 2018

New microfluidic device captures tumor-specific EVs to guide cancer diagnosis and treatment

Precision cancer treatment relies on obtaining molecular information about the tumor to guide effective treatment decisions.

8 May 2018

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck's anti-PD-1 therapy, KEYTRUDA®, along with chemotherapy.

8 May 2018

Use of psychiatric drugs soars in California jails

The number of jail inmates in California taking psychotropic drugs has jumped about 25 percent in five years, and they now account for about a fifth of the county jail population across the state, according to a new analysis of state data.

8 May 2018

Study shows cardiovascular problems are more common in uterine cancer survivors

A new study in the Journal of the National Cancer Institute indicates that survivors of uterine cancer are more likely to experience cardiovascular problems years after treatment.

8 May 2018

Using human induced pluripotent stem cells for therapeutic drug testing

Researchers at Li Ka Shing Faculty of Medicine of The University of Hong Kong have successfully demonstrated the use of human induced pluripotent stem cells from patients' skin cells for therapeutic drug testing.

8 May 2018

New FSMB report recommends best practices for regulating physicians' use of stem cell treatments

The Federation of State Medical Boards has released a report recommending best practices for regulating the promotion, communication and practices of treatments received at stem cell clinics in the United States.

8 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Functional loss of ARID1a, a frequently mutated tumor suppressor gene, causes deficiencies in normal DNA repair and may sensitize tumors to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer Center.

8 May 2018

Online survey shows patient dissatisfaction with hypothyroidism treatments

In the spring of 2017, 12,146 individuals with hypothyroidism responded to an online survey posted on a variety of websites and social media for two months by the Program Committee of the Satellite Symposium on Hypothyroidism, organized by the American Thyroid Association.

8 May 2018

Beaumont and GVSU team up to develop lifesaving cough-assist device

The act of coughing may seem annoying, but for those who can no longer cough on their own because of a medical condition, it's a matter of life and death. Today, more people are surviving brain/spinal cord injuries caused by stroke and automobile accidents.

7 May 2018

Cancer scientists confirm oligometastasis hypothesis

In 1995, two University of Chicago-based cancer specialists suggested there was an intermediate state - somewhere between curable localized cancers and lethal widespread disease - for patients with metastatic cancer.

7 May 2018

New review of infants with congenital hyperinsulinism shows surgery benefits

A review of nearly 500 cases of infants with severe congenital hyperinsulinism who underwent partial or near-total removal of their pancreas for persistent hypoglycemia at Children's Hospital of Philadelphia showed that surgeons can cure virtually all patients with the focal, or localized, form of the rare genetic disease.

7 May 2018

Scientists shed light on formation of new blood vessels

How new blood vessels form in mammals, for example during development or after injury, was so far not known exactly. Scientists at the Goethe University have now been able to shed light on this process.

7 May 2018

Research shows that amniotic fluid contains stem cells of kidney origin

Amniotic fluid, the liquid surrounding the fetus, can be routinely obtained without harming the mother or the baby. Previously, Prof. Dr. Adjaye's team and others demonstrated that amniotic fluid contains mesenchymal stem cells with great differentiation and regenerative potential.

7 May 2018

Tradeshow Talks with Keneric Healthcare

Tradeshow Talks with Keneric Healthcare at Health GB 2018.

7 May 2018

Researchers uncover protein linked to breast cancer metastasis

Jean-François Côté, a researcher at the Montreal Clinical Research Institute and professor at Université de Montréal's Faculty of Medicine, studies metastasis, the leading cause of cancer-related death. Recently, his team uncovered a protein that, once deactivated, could prevent the development of metastases in an aggressive type of cancer, HER2-positive breast cancer.

7 May 2018

Therapy News and Research

Bedfont takes new strides to enhance well-being of employees

Flushing the bladder with common chemotherapy drug after surgery can reduce bladder cancer recurrence

Invasive surgery should be done for select patients with acid reflux, says study

Centrosome amplification may contribute to initiation of cancers, research suggests

New microfluidic device captures tumor-specific EVs to guide cancer diagnosis and treatment

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Use of psychiatric drugs soars in California jails

Study shows cardiovascular problems are more common in uterine cancer survivors

Using human induced pluripotent stem cells for therapeutic drug testing

New FSMB report recommends best practices for regulating physicians' use of stem cell treatments

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Online survey shows patient dissatisfaction with hypothyroidism treatments

Beaumont and GVSU team up to develop lifesaving cough-assist device

Cancer scientists confirm oligometastasis hypothesis

New review of infants with congenital hyperinsulinism shows surgery benefits

Scientists shed light on formation of new blood vessels

Research shows that amniotic fluid contains stem cells of kidney origin

Tradeshow Talks with Keneric Healthcare

Researchers uncover protein linked to breast cancer metastasis

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News